Literature DB >> 20413381

Anomalous coronary origin: the challenge in preventing exercise-related sudden cardiac death.

C P Edwards1, A Yavari, M N Sheppard, S Sharma.   

Abstract

The sudden cardiac death (SCD) of a young athlete is a catastrophic event, particularly in the absence of prodromal warning symptoms. Anomalous coronary origin (ACO) is a well-described cause of cardiac symptoms and SCD, but the diagnosis is usually missed by conventional non-invasive investigations designed to identify myocardial ischaemia. SCD is preventable by correction of the anomaly. A tragic case of a promising young athlete who had underlying ACO and who presented with prodromal symptoms with multiple "negative" investigations is described to highlight the typical clinical features and outline the difficulties encountered in accurate premortem diagnosis.

Entities:  

Mesh:

Year:  2010        PMID: 20413381     DOI: 10.1136/bjsm.2008.054387

Source DB:  PubMed          Journal:  Br J Sports Med        ISSN: 0306-3674            Impact factor:   13.800


  4 in total

1.  Left circumflex arising from the right coronary artery and silent myocardial ischaemic damage: a potentially lethal disarray detected by cardiac CT and SPECT.

Authors:  Gian Piero Carboni; Pietro Sedati
Journal:  BMJ Case Rep       Date:  2013-11-06

Review 2.  Symptoms Preceding Sports-Related Sudden Cardiac Death in Persons Aged 1-49 Years.

Authors:  Emma Ritsmer Stormholt; Jesper Svane; Thomas Hadberg Lynge; Jacob Tfelt-Hansen
Journal:  Curr Cardiol Rep       Date:  2021-01-06       Impact factor: 2.931

Review 3.  Prevalence and spectrum diseases predisposing to sudden cardiac death: are they the same for both the athlete and the nonathlete?

Authors:  Anjan S Batra; Seshadri Balaji
Journal:  Pediatr Cardiol       Date:  2012-03       Impact factor: 1.655

4.  Sudden cardiac death while playing Australian Rules football: a retrospective 14 year review.

Authors:  Sarah Parsons; Matthew Lynch
Journal:  Forensic Sci Med Pathol       Date:  2016-03-14       Impact factor: 2.007

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.